Abstract: We present a global instruction scheduler based on integer linear programming (ILP) that was implemented experimentally in the Intel Itaniumreg product compiler. It features virtually the ...

TWC Forum used vBulletin 4 software. We did, multiple times, try to upgrade to vB5, but it did not go through successfully. The URLs changed completely and that was bad! Moreover, support for ...

and a vision for the future of enterprise software. Podduturi reinvented the frontend for scalability and resilience in big corporations through his work. His contributions highlight the accelerating ...

The US Copyright Office's report comes as the agency is under political fire, with President Trump reportedly firing its head this weekend. Katelyn is a writer with ...

Smith Micro Software, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.11. Operator: Good day, and welcome to the Smith Micro First Quarter 2025 Earnings ...

Smith Micro Software Inc (NASDAQ:SMSI) is making significant progress with its SafePath OS for kids and senior phones, which aligns with mobile operators' core business strengths. The company is ...

Thank you, operator, and good afternoon, everyone. We appreciate you joining us today to discuss Smith Micro Software financial results for the first quarter ended March 31, 2025. By now ...

Smith Micro Software, Inc. (SMSI) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.45 per share a year ago.

Smith Micro Software (SMSI) reported its Q1 2025 financial results, highlighting a decline in revenue and a notable stock price movement. According to InvestingPro analysis, the company currently ...

Note: (Loss) earnings per share: basic and diluted - may be impacted by rounding to allow rows to calculate. 1Adjustment for Non-Recurring Items includes costs associated with corporate actions in ...

titled “Methods for Treating Tumors,” expands protection of methods for drug delivery with RenovoRx’s Trans-Arterial Micro-Perfusion (TAMP™) therapy platform, enabled by the Company’s ...